| Q1：How is a User defined? |
A1：
|
User registration is required to post patents for drugs/drug candidates, platform technologies, reagents, and diagnostics drugs.
Users include “Users” and “Member Users”, with each User able to browse and post within the limitations as shown in the chart below.
Users may post SELL Items at no charge until the end of March 2008. In addition to viewing detailed SELL Item information; “Member Users” are eligible to place orders for purchasing of items of interest.
Please access the following page for the benefits of being a“Member User”.
| |
|
Visitors |
Users |
Member Users |
| SELL Items |
Browse |
Basic Info |
Y |
Y |
Y |
| Detailed Info |
N |
N |
Y |
| Posting |
N |
Y |
Y |
| BUY Items |
Browse |
Y |
Y |
Y |
| Posting |
N |
N |
Y |
|
| Q2：How do I register as a User? |
A2： |
You can register free of charge.
Please fill in the necessary information on the registration form. You can use this site as a “User” once the registration process has been completed.
* The email address used for user registration will be used as your user ID to login.
Remember your user ID and password (6-10 letters and numbers).
* You can also apply for Member User registration at the same time.
You will be eligible to use this site as a “Member User” after you submit the application for enrollment and remit the membership fee (required documents will be sent from the Administrator).
|
| Q3：How do I post a SELL Item? |
A3： |
User registration is required to post SELL Items. The posting of SELL Items will be accepted at no charge until the end of March 2008.
|
| Q4：What can be posted as a SELL Item? |
A4： |
First, please select an item category (either “Drug/Drug Candidate,” “Platform Technology,” or “Reagent/Diagnostic”) and the language you would like to post information (English or Japanese), and complete the form.
(* Required fields)
(Basic information is freely accessible and open to public)
(□ is a field to be selected.)
【Drug/drug candidate, Reagent/diagnostic】
Therapeutic Area *
(Basic information) |
Treatment Parts
□Dermal □Cardiovascular □Gastrointestinal □Urinary tract □Central nervous system □Locomotorium □Other
Target Disease
□Cancer □Immunological disorder □Allergy □Metabolic disease (Diabetes, Hyperlipidemia) □Infectious disease □ Inflammation
□Pain control □Other
|
Title of the offered Technology *
(Basic information) |
(max. 100 characters) |
Outline of the offered Technology *
(Basic information) |
(max. 2,400 characters) |
| Target Disease |
(max. 1,600 characters, please itemize.) |
| Market Size |
(max. 2,400 characters) |
| Action Mechanism |
(max. 2,400 characters) |
| Administration Method |
□Oral administration □Intravenous injection □Dermal administration □Instillation □Nasal Drip □Other □No selection |
Development Stage*
(Basic information) |
□In vitro □In vivo □Immediately proceeding with clinical testing (within 2 years)
□Phase I □Phase II and/or later stage
|
| Reason for Discontinued development |
(max. 2,400 characters) |
| Safety/toxicity Test results |
(max. 2,400 characters) |
| In vitro Test results |
(max. 2,400 characters) |
| In vivo Test results |
(max. 2,400 characters) |
| Type of patent * |
□Product patent □Process patent □Use Patent □Formulation patent □Other |
Patent countries (and those expected) *
Entry of patent number/posting number is optional. |
Japan
□No intention of getting a patent □Yet to apply □Already applied
□Patented or registered → Patent number: No.______________________________ (ex. 2000-123456)
Expiration date:↓ ___ year ↓ ___ month ↓ ___ date
*The same input fields as Japan should be used for U.S.A., U.K., Germany, France, and other nations.
PCT application
□No intention of getting a patent □Yet to apply □ Already applied
□ Patented or registered → □Intended for all affiliated countries □Intended for some
Patent number: No. ______________________________
EP application
□No intention of getting a patent □Yet to apply □Already applied
□Patented or registered → □Intended for all affiliated countries □Intended for some
Patent number: No. ______________________________
Total: Obtained in ____ countries (and those expected) |
| Comments on patent |
(max. 2,400 characters) |
Association category *
(Basic information) |
□University and public research institute □TLO □Bio venture
□Pharmaceutical company □Other businesses □Individual □Other
|
| Institution/company name |
(max. 100 characters) |
| Location of institution/company |
□Japan □ Asia □North America □EU □Others □No selection |
| Do you have know-how of production? * |
□Yes □No |
| Comments on your know-how of production |
(max. 2,400 characters) |
| Do you have a sample? * |
□Yes □No |
| Comments about your sample |
(max. 2,400 characters) |
| Do you have assessment data * |
□Yes □No |
| Comments about your assessment data |
(max. 2,400 characters) |
Preferred method of contract*
(Basic information) |
(Multiple selections allowed)
□Buying/selling patent □Exclusive license □Non-exclusive license
□Joint research □Subject to negotiation Other
|
| Requested amount of minimum advance guarantee upon contract |
□JPY1 million or less □JPY1 million or more
□JPY3 million or more □JPY5 million or more □JPY10 million or less
□JPY30 million or more □JPY50 million or more □Not specified
|
| Please list any other comments here |
(max. 2,400 characters) |
【Platform technology】
Purpose *
(Basic information) |
□DDS □Screening □Pharmacokinetic analysis □Animal model
□Pharmaceutical technology □Manufacturing-related □Genome □Other
|
Title of the offered Technology *
(Basic information) |
(max. 100 characters) |
Outline of the offered Technology *
(Basic information) |
(max. 2,400 characters) |
| Type of patent * |
□Product patent □Process patent □Use Patent □Formulation patent □Other |
Patent countries (and those expected) *
Entry of patent number/posting number is optional. |
Japan
□No intention of getting a patent □Yet to apply □Already applied
□Patented of registered → Patent number: No. ______________________________ (ex. 2000-123456)
Expiration date: ↓ ___ year ↓ ___ month ↓ ___ date
* The same input fields as Japan should be used for U.S.A., U.K., Germany, France, and other nations.
PCT application
□No intention of getting a patent □Yet to apply □Already applied
□Patented of registered → □Intended for all affiliated countries □Intended for some
Patent number: No. ______________________________
EP application
□No intention of getting a patent □Yet to apply □Already applied
□Patented of registered → □Intended for all affiliated countries □Intended for some
Patent number: No. ______________________________
Total: Obtained in ____ countries (and those expected) |
| Comments on patent |
(max. 2,400 characters) |
Association category *
(Basic information) |
□University and public research institute □TLO □Bio venture
□Pharmaceutical company □Other businesses □Individual □Other |
| Institution/company name |
(max. 100 characters) |
| Location of institution/company |
□Japan □Asia □North America □EU □Others □No selection |
Preferred method of contract*
(Basic information) |
(Multiple selections allowed)
□Buying/selling patent □Exclusive license □Nonexclusive license
□Joint research □Subject to negotiation □Other |
| Requested amount of minimum advance guarantee upon contract |
□JPY1 million or less □JPY1 million or more □JPY3 million or more □JPY5 million or more
□JPY10 million or more □JPY30 million or more □JPY50 million or more □Not specified |
| Please list any other comments here |
(max. 2,400 characters) |
|
 |
| Q5：How do I post a BUY Item? |
A5： |
Only Member Users are eligible to post BUY Items. If you register as Member User, the 18-month period from October 2006 to March 2008 will be covered by an enrollment fee and the 12-month membership fee.
（Please view the Benefits of Member User Registration.）
|
| Q6：What can be posted as a BUY Item? |
A6： |
First, please select an item category (either “Drug/Drug Candidate,” “Platform Technology,” or “Reagent/Diagnostic” and the language you would like to post information (English or Japanese)), and complete the form.
(* Required fields)
(□is a field to be selected.)
【Drug/Drug candidate, Reagent/Diagnostic】
| Therapeutic Area |
Treatment Parts
□Dermal □Cardiovascular □Gastrointestinal □Urinary tract □Central nervous system □Locomotorium □Other
Target Diseases
□Cancer □Immunological disorder □Allergy □Metabolic disease (Diabetes, Hyperlipidemia) □Infectious disease □Inflammation
□Pain control □Other |
| Title of the offered Technology * |
(Max. 100 characters) |
| 希望技術の概要※ |
(Max. 2,400 characters) |
| Target Disease |
(Max. 1,600 characters, please itemize.) |
| Administration Method |
□Oral administration □Intravenous injection □Dermal administration □Instillation □Nasal Drip □Other □No selection |
| Development Stage |
□In vitro □In vivo □Immediately proceeding with clinical testing (within 2 years)
□Phase I □Phase II and/or later stage |
| Association category * |
□University and public research institute □TLO □Bio venture
□Pharmaceutical company □Other businesses □Individual □Other |
| Preferred method of contract * |
(Multiple selections allowed)
□Buying/selling patent □Exclusive license □Nonexclusive license
□Joint research □Subject to negotiation □Other |
| Requested amount of minimum advance guarantee upon contract |
□JPY1 million or less □JPY1 million or more □JPY3 million or more □JPY5 million or more
□JPY10 million or more □JPY30 million or more □JPY50 million or more □Not specified |
【Platform technology】
| Purpose |
□DDS □Screening □Pharmacokinetic analysis □Animal model
□Pharmaceutical technology □Manufacturing-related □Genome □Other |
| Title of the offered Technology * |
(max. 100 characters) |
| Outline of the offered Technology * |
(max. 2,400 characters) |
| Association category * |
□University and public research institute □TLO □Bio venture
□Pharmaceutical company □Other businesses □Individual □Other |
| Preferred method of contract* |
(Multiple selections allowed)
□Buying/selling patent □Exclusive license □Nonexclusive license
□Joint research □Subject to negotiation □Other |
| Requested amount of minimum advance guarantee upon contract |
□JPY1 million or less □JPY1 million or more □JPY3 million or more □JPY5 million or more
□JPY10 million or more □JPY30 million or more □JPY50 million or more □Not specified |
|
|
|
